Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization

Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization

The rapid transmission of SARS-CoV-2 in the USA and worldwide necessitates the development of multiple vaccines to combat the COVID-19 global pandemic. Previously, we showed that a particulate adjuvant system, quil-A-loaded chitosan (QAC) nanoparticles, can elicit robust immunity combined with plasm...

Full description

Bibliographic Details
Main Authors: Shaswath S. Chandrasekar, Yashdeep Phanse, Rachel E. Hildebrand, Mostafa Hanafy, Chia-Wei Wu, Chungyi H. Hansen, Jorge E. Osorio, M. Suresh, Adel M. Talaat
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
intranasal vaccine
nanovaccine
heterologous vaccine
Online Access:https://www.mdpi.com/2076-393X/9/2/132

Internet

https://www.mdpi.com/2076-393X/9/2/132

Similar Items